Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR Test for quantification of different subtypes of human immunodeficiency virus type 1

Journal of Clinical Microbiology

Volumn 37, Issue 1, 1999, Pages 110-116

  Triques, K ^a   Coste, J ^b   Perret, J L ^d   Segarra, C ^b   Mpoudi, E ^e   Reynes, J ^c   Delaporte, E ^a   Butcher, A ^f   Dreyer, K ^f,g   Herman, S ^f   Spadoro, J ^f   Peeters, M ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Laboratoire de Virologie Moleculaire   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d LAVERAN MILITARY TEACHING HOSPITAL   (France)

^e Hôpital Militaire de Yaoundé   (Cameroon)

^f HOFFMANN LA ROCHE INC   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC VALUE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032921188     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.1.110-116.1999     Document Type: Article

References (48)

1. Alaeus, A., K. Lidman, A. Sönnerborg, and J. Albert. 1997. Subtype specific problems with quantification of plasma HIV-1 RNA. AIDS 11:859-865.
2. Alaeus, A., T. Leitner, K. Lidman, and J. Albert. 1997. Most HIV-1 genetic subtypes have entered Sweden. AIDS 11:199-202.
3. Arnold, C., K. L. Barlow, J. V. Parry, and J. P. Clewley. 1995 At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. AIDS Res. Hum. Retroviruses 11:427-429.
4. Arnold, C., K. L. Barlow, S. Kaye, C. Loveday, P. Balfe, and J. P. Clewley. 1995. HIV type 1 sequence subtype G transmission from mother to infant: failure of variant sequence species to amplify in the Roche AMPLICOR test. AIDS Res. Hum. Retroviruses 8:999-1001.
5. Barin, F., A. M. Courouce, J. Pillonel, and L. Buzelay. 1997. The retrovirus study group of the French society of blood transfusion: increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). AIDS 11:1503-1508.
6. Birx, D. L. 1996. Summary of track A: basic science. AIDS 10(Suppl. 3):S85-S106.
7. Bland, J. M., and D. G. Altman. 1995. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346: 1085-1087.
8. Brodine, S. K., J. R. Mascola, P. J. Weiss, S. I. Ito, K. P. Porter, A. W. Artenstein, F. C. Garland, F. E. McCutchan, and D. S. Burke. 1995. Detection of diverse HIV-1 genetic subtypes in the United States. Lancet 346: 1198-1199.
9. Bush, C. E., R. M. Donovan, O. Manzor, D. Baxa, E. Moore, F. Cohen, and L. D. Saravdatz. 1996. Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia and unintegrated DNA as viral load markers in pediatric patients. AIDS Res. Hum. Retroviruses 12:11-15.
10. Carr, J. K., M. O. Salminer, J. Albert, E. Sanders-Buell, D. Gotte, D. L. Birx, and F. E. McCutchan. 1998. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinant. Virology 247:22-31.
11. Christopherson, C. D., and S. Kwok. 1996. The effects of mutations on HIV-1 quantitation by RT/PCR, abstr. MoA161. In Abstracts of the XI International Conference on AIDS.
12. Cornelissen, M., G. Kampinga, F. Zorgdrager, J. Goudsmit, and the UN-AIDS Network for HIV Isolation and Characterization. 1996. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. J. Virol. 70:8209-8212.
13. Coste, J., B. Montes, J. Reynes, M. Peeters, C. Segarra, J. P. Vendrell, E. Delaporte, and M. Segondy. 1996. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50:293-302.
14. Delwart, E. L., E. G. Shpaer, F. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J. I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
15. DiDomenico, N., H. Link, R. Knobel, T. Caratsch, W. Weschler, Z. G. Loewy, and M. Rosentraus. 1996. COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. Clin. Chem. 42:1915-1923.
16. Dietrich, U., H. Ruppach, S. Gehring, H. Knechten, M. Knickmann, H. Jager, E. Wolf, R. Husak, C. E. Orfanos, H. D. Brede, H. Rubsamen-Waigman, and H. von Briesen. 1997. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS 11:1532-1533.
17. Expert Group of the Joint United Nations Programme on HIV/AIDS. 1997. Implications of HIV variability for transmission: scientific and politic issues. AIDS 11:UNAIDS1-UNAIDS15.
18. Fransen, K., A. Buvé, J. N. Nkengasong, M. Laga, and G. van der Groen. 1996. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 347:1403. (Letter.)
19. Gobbers, E., K. Fransen, T. Oosterlaken, W. Janssens, L. Heyndrickx, T. Ivens, K. Vereecken, P. van de Wiel, and G. van der Groen. 1997. Reactivity and amplification system with regard to different HIV-1 subtypes. J. Virol. Methods 66:293-301.
20. Harrigan R. 1995. Measuring viral load in the clinical setting. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10(Suppl):S34-S40.
21. Kievits, T., P. Rothbart, W. Quint, H. Huisman, J. Goudsmit, and P. Lens. 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35:273-286.
22. Lasky, M., J. L. Perret, M. Peeters, F. Bibollet-Ruche, F. Liegeois, D. Patrel, S. Mulinier, C. Gras, and E. Delaporte. 1997. Presence of non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 11:43-51.
23. Layne, S. P., M. J. Merges, M. Dembo, et al. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human im-munodeficiency virus. Virology 189:695-714.
24. Leitner, T. 1996. Genetic subtypes of HIV-1. In Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos. N.M.
25. Loussert-Ajaka, I., D. Descamps, K. Simon, F. Brun-Vezinet, M. Ekwalanga, and S. Saragosti. 1995. Genetic diversity and HIV detection by polymerase chain reaction. Lancet 346:912-913.
26. Loussert-Ajaka, I., M. L. Chaix, B. Korber, F. Letourneur, E. Gomas, E. Allen, T. D. Ly, F. Brun-Vezinet, F. Simon, and S. Saragosti. 1995. Variability of human immunodeficiency virus type-1 group O strains isolated from Cameroonian patients living in France. J. Virol. 69:5640-5649.
27. Loussert-Ajaka, I., T. D. Ly, ML. Chaix, D. Ingrand, S. Saragosti, A. M. Courouce, F. Brun-Vezinet, and F. Simon. 1994. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 343:1393-1394.
28. Louwagie, J. J., E. L. Delwart, J. I. Mullins, F. E. McCutchan, G. Eddy, and D. S. Burke. 1994. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res. Hum. Retroviruses 10: 561-567.
29. Louwagie, J. J., F. E. McCutchan, M. Peeters, T. Brennan, E. Sanders-Buell, G. Eddy, G. van der Groen, K. Fransen, M. Gershy-Damet, R. Deleys, and D. Burke. 1993. Phylogenetic analysis of gag genes from seventy international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
30. Louwagie, J. J., W. Janssens, J. J. Mascola, C. L. Fischer, P. A. Hegerich, G. van der Groen, F. E. McCutchan, G. Eddy, and D. Burke. 1995. Genetic diversity of the HIV-1 envelope glycoprotein. J. Virol. 69:263-271.
31. Mascola, J. J., J. J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1993. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
32. McCutchan, F. E., M. O. Salminen, J. K. Carr, and D. S. Burke. 1996. HIV genetic diversity. AIDS 10(Suppl. 3):S13-S20.
33. McCutchan, F. E., P. A. Hegerich, T. P. Brennan, P. Phanuphak, P. Singharaj, A. Jugsudee, P. W. Herman, A. M. Gray, A. K. Fowler, and D. S. Burke. 1992. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1887-1895.
34. Mellors, J., L. Kingsley, C. Rinaldo, J. Todd, B. Hoo, R. Kokka, and P. Gupta. 1995. Ouantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
35. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
36. Michael, N. (Walter Reed Arm; Institute of Research, Rockville, Md.). Personal communication.
37. Myers, G., B. Korber, B. Hahn, K. T. Jeang, J. W. Mellors, F. E. McCutchan, L. E. Henderson, and G. N. Pavlakis. 1995. A compilation of analysis of nucleic acid and amino acid sequences. In Human retrovirus and AIDS. Los Alamos National Laboratory, Los Alamos, N.M.
38. Peeters, M., A. Gueye, S. Mboup, F. Bibollet-Ruche, E. Ekaza, C. Mulanga, R. Ouedrago, R. Gandji, P. Mpele, G. Dibanga, B. Koumare, M. Saidou, E. Esu-Williams, J. P. Lombart, W. Badombena, N. Luo, M. van den Haesevelde, and E. Delaporte. 1997. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 11:493-498.
39. Porter, K. R., J. R. Mascola, H. Hupudio, D. Ewing, T. C. VanColt, R. L. Anthony, A. L. Gorwin, S. Widodo, S. Ertono, F. E. McCutchan, D. S. Burke, C. G. Haves, F. S. Wignall, and R. R. Graham. 1997. Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:1-6.
40. Ravfield, M. A., P. Sullivan, C. I. Bandea, L. Britvan, R. A. Otten, C. P. Pau, D. Pieniazek, S. Subbarao, P. Simon, C. A. Schable, A. C. Wright, J. Ward, and G. Schochetman. 1996. HIV-1 group O virus identified for the first time in the United States. Emerg. Infect. Dis. 2:209-212.
41. Revels, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, AM-PLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
42. 6/1. AIDS 10: F39-F44.
43. Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nat. Med. 2:625-629.
44. Salminen, M. O., B. Johansson, A. Sonnerborg, S. Ayehunie, D. Gotte, P. Leinikki, D. S. Burke, and F. E. McCutchan. 1996. Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res. Hum. Retroviruses 12:1329-1339.
45. Schable, C., L. Zekeng, C. P. Pau, D. Hu, L. Kaptue, L. Gurtler, T. Dondero, J. M. Tsague, G. Schochetman, H. Jaffe, and J. R. George. 1994. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 344:1333-1334.
46. Simon, F., I. Loussert-Ajaka, F. Damond, S. Saragosti, F. Barin, and F. Brun-Venizet. 1996. HIV type 1 diversity in northern Paris, AIDS Res Hum. Retroviruses 12:1427-1433.
47. Urdea, M. S. 1993. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 7 (Suppl. 2):S11-S14.
48. Vandamme, A. M., J. C. Schmit, S. Van Dooren, K. Van Laethem, E. Gobbers, W. Kok, P. Goubau, M. Witvrouw, W. Peetersmans, E. De Clercq, and J. Desmyter. 1996. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and AMPLICOR HIV Monitor test. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:127-139.